Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-06

Clinical Trial Update: Vitamin D Supplementation in HIV Youth [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating vitamin D supplementation in HIV-infected youth has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholecalciferol (Vitamin D3) (cholecalciferol)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: HIV Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-02-06